Blog

Considerations for Quality Agreements

Considerations for Quality Agreements

It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for several reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.

Parallel Trade – A reminder

Parallel Trade – A reminder

Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.

Journalists – Be Careful What You Write About Medicines

Journalists – Be Careful What You Write About Medicines

The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.

Emerging Risks in Pharmacy Practice: Key Updates from the GPhC

Emerging Risks in Pharmacy Practice: Key Updates from the GPhC

In this blog I want to highlight some critical updates from the General Pharmaceutical Council (GPhC) that every pharmacy professional—whether you’re a pharmacist, technician, or pharmacy owner—should be aware of. These issues have prompted serious regulatory concerns and demand thoughtful consideration and action where appropriate.